Alexandra Goll

Alexandra Goll

Direktor/Vorstandsmitglied bei
Biovertis AG
70 Jahre
Health Technology
Finance
Consumer Services

Profil

Ms. Alexandra Goll is General Partner at TVM Capital GmbH which she joined in 1998.
She is also Mitglied des Vorstands at Addex Pharmaceuticals SA. She is on the Board of Directors at Biovertis AG, Arrow Therapeutics Ltd., Cerenis Therapeutics Holding SA, and Albireo AB. Dr. Goll also served on the board at Pharmasset, Inc. Prior to her affiliation with TVM, Dr. Goll was the Global Business Leader for HIV and CMV, and was responsible for strategic marketing and business development for Virology at Roche Ltd. in Basel.
She had been involved in clinical development and managing commercialisation strategies of several products.
Dr. Alexandra Goll holds a degree in pharmacy from the Free University of Berlin, and wrote her doctoral dissertation in natural sciences at Philipps University of Marburg.

Aktive Positionen von Alexandra Goll

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Alexandra Goll

UnternehmenPositionEnde
HEIDELBERG PHARMA AG Direktor/Vorstandsmitglied 14.12.2011
ADDEX THERAPEUTICS LTD Corporate Officer/Principal 17.04.2008
Direktor/Vorstandsmitglied 02.11.2007
IDENIX PHARMACEUTICALS INC Direktor/Vorstandsmitglied 01.05.2003
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Alexandra Goll im Detail an

Ausbildung von Alexandra Goll

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

33

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Alexandra Goll